Jump to Content Jump to Main Navigation

Accepted Manuscripts

in Endocrine-Related Cancer

Online ISSN:: 1479-6821

Print ISSN:: 1351-0088

Effects of epigenetic pathway inhibitors on corticotroph tumour AtT20 cells

Author(s): Kate E Lines, Panagis Filippakopoulos, Mark Stevenson, Susanne Muller, Helen E Lockstone, Benjamin Wright, Stefan Knapp, David Buck, Chas Bountra and Rajesh V Thakker
IGF2 drives formation of ileal neuroendocrine tumors in patients and mice

Author(s): Tanupriya Contractor, Richard Clausen, Grant Harris, Jeffrey Rosenfeld, Darren Carpizo, Laura Tang and Chris Harris
Innovative imaging of insulinoma: the end of sampling? A review

Author(s): Emanuel Christ, Kwadwo Antwi, Melpomeni Fani and Damian Wild
p300 is up-regulated by docetaxel and is a target in chemoresistant prostate cancer

Author(s): Martina Gruber, Lavinia Ferrone, Martin Puhr, Frédéric R Santer, Tobias Furlan, Iris E. Eder, Natalie Sampson, Georg Schäfer, Florian Handle and Zoran Culig
The prognostic value of AR in HER2-enriched metastatic breast cancer

Author(s): Xinyue Wang, Xiwen Bi, Zhangzan Huang, Jiajia Huang, Wen Xia, Wei Shi and Zhongyu Yuan
Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer

Author(s): Woo Kyung Lee, Won Gu Kim, Laura Fozzatti, Sunmi Park, Li Zhao, Mark Willingham, David Lonard, Bert W O'Malley and Sheue-yann Cheng

Top

Print ISSN:: 1351-0088

Online ISSN:: 1479-6821

Access brought to you by: Massachusetts Inst of Technology

© 2020 Bioscientifica Ltd

Follow us on: Share Share

Print ISSN: 1351-0088; Online ISSN: 1479-6821 Powered by: